REPORT ID 6548

EMEA (Europe, Middle East and Africa) Erythropoietin Drugs Market Report 2017

Publish Date
26-Dec-17
Pages
105
Format
Electronic (PDF)

In this report, the EMEA Erythropoietin Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K ML), revenue (Million USD), market share and growth rate of Erythropoietin Drugs for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Erythropoietin Drugs market competition by top manufacturers/players, with Erythropoietin Drugs sales volume (K ML), price (USD/ML), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Amgen
    Johnson & Johnson
    Hospira
    Roche
    LG Life Sciences
    Biocon
    Intas Pharmaceuticals
    Teva Pharmaceutical Industries
    Ranbaxy Laboratories
    Celltrion

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Natural Erythropoietin
    Non-natural Erythropoietin

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Anemia
    Kidney Disorders
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Erythropoietin Drugs Market Report 2017
1 Erythropoietin Drugs Overview
    1.1 Product Overview and Scope of Erythropoietin Drugs
    1.2 Classification of Erythropoietin Drugs
        1.2.1 EMEA Erythropoietin Drugs Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Erythropoietin Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Natural Erythropoietin
        1.2.4 Non-natural Erythropoietin
    1.3 EMEA Erythropoietin Drugs Market by Application/End Users
        1.3.1 EMEA Erythropoietin Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Anemia
        1.3.3 Kidney Disorders
        1.3.4 Other
    1.4 EMEA Erythropoietin Drugs Market by Region
        1.4.1 EMEA Erythropoietin Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Erythropoietin Drugs (2012-2022)
        1.5.1 EMEA Erythropoietin Drugs Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Erythropoietin Drugs Revenue and Growth Rate (2012-2022)

2 EMEA Erythropoietin Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Erythropoietin Drugs Market Competition by Players/Manufacturers
        2.1.1 EMEA Erythropoietin Drugs Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Erythropoietin Drugs Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Erythropoietin Drugs Sale Price by Players (2012-2017)
    2.2 EMEA Erythropoietin Drugs (Volume and Value) by Type/Product Category
        2.2.1 EMEA Erythropoietin Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Erythropoietin Drugs Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Erythropoietin Drugs Sale Price by Type (2012-2017)
    2.3 EMEA Erythropoietin Drugs (Volume) by Application
    2.4 EMEA Erythropoietin Drugs (Volume and Value) by Region
        2.4.1 EMEA Erythropoietin Drugs Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Erythropoietin Drugs Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Erythropoietin Drugs Sales Price by Region (2012-2017)

3 Europe Erythropoietin Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Erythropoietin Drugs Sales and Value (2012-2017)
        3.1.1 Europe Erythropoietin Drugs Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Erythropoietin Drugs Revenue and Growth Rate (2012-2017)
    3.2 Europe Erythropoietin Drugs Sales and Market Share by Type
    3.3 Europe Erythropoietin Drugs Sales and Market Share by Application
    3.4 Europe Erythropoietin Drugs Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Erythropoietin Drugs Sales Volume by Countries (2012-2017)
        3.4.2 Europe Erythropoietin Drugs Revenue by Countries (2012-2017)
        3.4.3 Germany Erythropoietin Drugs Sales and Growth Rate (2012-2017)
        3.4.4 France Erythropoietin Drugs Sales and Growth Rate (2012-2017)
        3.4.5 UK Erythropoietin Drugs Sales and Growth Rate (2012-2017)
        3.4.6 Russia Erythropoietin Drugs Sales and Growth Rate (2012-2017)
        3.4.7 Italy Erythropoietin Drugs Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Erythropoietin Drugs Sales and Growth Rate (2012-2017)

4 Middle East Erythropoietin Drugs (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Erythropoietin Drugs Sales and Value (2012-2017)
        4.1.1 Middle East Erythropoietin Drugs Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Erythropoietin Drugs Revenue and Growth Rate (2012-2017)
    4.2 Middle East Erythropoietin Drugs Sales and Market Share by Type
    4.3 Middle East Erythropoietin Drugs Sales and Market Share by Application
    4.4 Middle East Erythropoietin Drugs Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Erythropoietin Drugs Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Erythropoietin Drugs Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Erythropoietin Drugs Sales and Growth Rate (2012-2017)
        4.4.4 Israel Erythropoietin Drugs Sales and Growth Rate (2012-2017)
        4.4.5 UAE Erythropoietin Drugs Sales and Growth Rate (2012-2017)
        4.4.6 Iran Erythropoietin Drugs Sales and Growth Rate (2012-2017)

5 Africa Erythropoietin Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Erythropoietin Drugs Sales and Value (2012-2017)
        5.1.1 Africa Erythropoietin Drugs Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Erythropoietin Drugs Revenue and Growth Rate (2012-2017)
    5.2 Africa Erythropoietin Drugs Sales and Market Share by Type
    5.3 Africa Erythropoietin Drugs Sales and Market Share by Application
    5.4 Africa Erythropoietin Drugs Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Erythropoietin Drugs Sales Volume by Countries (2012-2017)
        5.4.2 Africa Erythropoietin Drugs Revenue by Countries (2012-2017)
        5.4.3 South Africa Erythropoietin Drugs Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Erythropoietin Drugs Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Erythropoietin Drugs Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Erythropoietin Drugs Sales and Growth Rate (2012-2017)

6 EMEA Erythropoietin Drugs Manufacturers/Players Profiles and Sales Data
    6.1 Amgen
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Erythropoietin Drugs Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Amgen Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Johnson & Johnson
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Erythropoietin Drugs Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Johnson & Johnson Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Hospira
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Erythropoietin Drugs Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Hospira Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Roche
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Erythropoietin Drugs Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Roche Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 LG Life Sciences
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Erythropoietin Drugs Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 LG Life Sciences Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Biocon
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Erythropoietin Drugs Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Biocon Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Intas Pharmaceuticals
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Erythropoietin Drugs Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Intas Pharmaceuticals Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Teva Pharmaceutical Industries
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Erythropoietin Drugs Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Teva Pharmaceutical Industries Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Ranbaxy Laboratories
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Erythropoietin Drugs Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Ranbaxy Laboratories Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Celltrion
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Erythropoietin Drugs Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Celltrion Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Erythropoietin Drugs Manufacturing Cost Analysis
    7.1 Erythropoietin Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Erythropoietin Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Erythropoietin Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Erythropoietin Drugs Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Erythropoietin Drugs Market Forecast (2017-2022)
    11.1 EMEA Erythropoietin Drugs Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Erythropoietin Drugs Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Erythropoietin Drugs Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Erythropoietin Drugs Price and Trend Forecast (2017-2022)
    11.2 EMEA Erythropoietin Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Erythropoietin Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Erythropoietin Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Erythropoietin Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Erythropoietin Drugs Sales Forecast by Type (2017-2022)
    11.7 EMEA Erythropoietin Drugs Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer